Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1884666

CCCn1cc[n+](C)c1C.[Cl-]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 2/20 0.47
CA1 P00915 6/20 0.40
CA2 P00918 6/20 0.40
KMT2A Q03164 3/20 0.37
EEF2K O00418 2/20 0.37
EEF2 P13639 2/20 0.37
MEN1 O00255 2/20 0.37
PLK4 O00444 1/20 0.37
JAK2 O60674 1/20 0.37
EGFR P00533 1/20 0.37
TYK2 P29597 1/20 0.37
FLT3 P36888 1/20 0.37
BLM P54132 1/20 0.37
ITK Q08881 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
HDAC8 Q9BY41 4/20 0.35
POLB P06746 2/20 0.33
APOBEC3A P31941 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL319282 0.98 ACHE (0.45) ACHECA1CA2KMT2AEEF2K
Bromide SCHEMBL8204076 0.96 CA1 (0.44) ACHECA1CA2KMT2AEEF2K
Iodide SCHEMBL302515 0.96 ACHE (0.44) ACHECA1CA2KMT2AEEF2K
Water SCHEMBL15365841 0.96 ACHE (0.44) ACHECA1CA2KMT2AEEF2K
Fluoride Ion SCHEMBL21980194 0.96 ACHE (0.44) ACHECA1CA2KMT2AEEF2K
SCHEMBL15732265 0.90 ACHE (0.41) ACHECA1CA2KMT2AEEF2K
SCHEMBL28698375 0.90 ACHE (0.41) ACHECA1CA2KMT2AEEF2K
SCHEMBL61367 0.90 LMNA (0.42) ACHECA1CA2KMT2AEEF2K
SCHEMBL15348251 0.90 ACHE (0.41) ACHECA1CA2KMT2AEEF2K
Hydrochloric Acid SCHEMBL295048 0.88 KMT2A (0.47) ACHECA1CA2KMT2AEEF2K

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240183817-A1 Solid-state Reference Electrode Based on Polymeric Membrane GLAS TRUST COMPANY LLC 2024-06-06 US claimed
CN-111224163-B Electrolyte composition and metal ion battery comprising same 财团法人工业技术研究院 2022-02-22 CN claimed
US-11258100-B2 Electrolyte composition and metal-ion battery employing the same INDUSTRIAL TECHNOLOGY RESEARCH INTITUTE (TW) 2022-02-22 US claimed
CN-111224163-A Electrolyte composition and metal ion battery comprising same 财团法人工业技术研究院 2020-06-02 CN claimed
US-20200168954-A1 ELECTROLYTE COMPOSITION AND METAL-ION BATTERY EMPLOYING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2020-05-28 US claimed
CN-108767303-A A kind of semi-solid flow cell 山东科技大学 2018-11-06 CN claimed
CN-108321394-A A kind of Dual-ion cell and preparation method thereof 山东科技大学 2018-07-24 CN claimed
CN-104136445-B Synthesis of organohalosilane monomers by enhanced cracking of direct Process residue 莫门蒂夫性能材料股份有限公司 2017-11-03 CN claimed
CN-104144934-B Synthesis of organohalosilane monomers from conventional non-crackable direct process residues 莫门蒂夫性能材料股份有限公司 2017-04-26 CN claimed
EP-2797935-B1 SYNTHESIS OF ORGANOHALOSILANE MONOMERS VIA ENHANCED CLEAVAGE OF DIRECT PROCESS RESIDUE MOMENTIVE PERFORMANCE MAT INC (US) 2016-03-09 EP claimed
EP-2797936-A1 SYNTHESIS OF ORGANOHALOSILANE MONOMERS FROM CONVENTIONALLY UNCLEAVABLE DIRECT PROCESS RESIDUE Momentive Performance Materials Inc. (US) 2014-11-05 EP claimed
US-8715853-B1 Aluminum batteries comprising metal-oxide, metal-fluoride, metal-sulfide, or sulfur cathodes HRL LABORATORIES, LLC (US) 2014-05-06 US claimed
US-8697901-B2 Synthesis of organohalosilane monomers via enhanced cleavage of direct process residue MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2014-04-15 US claimed
US-8637695-B2 Synthesis of organohalosilane monomers from conventionally uncleavable Direct Process Residue MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2014-01-28 US claimed
US-20130172593-A1 Synthesis of Organohalosilane Monomers From Conventionally Uncleavable Direct Process Residue MOMENTIVE PERFORMANCE MATERIALS INC. 2013-07-04 US claimed
WO-2013101618-A1 SYNTHESIS OF ORGANOHALOSILANE MONOMERS VIA ENHANCED CLEAVAGE OF DIRECT PROCESS RESIDUE MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2013-07-04 WO claimed
WO-2013101619-A1 SYNTHESIS OF ORGANOHALOSILANE MONOMERS FROM CONVENTIONALLY UNCLEAVABLE DIRECT PROCESS RESIDUE MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2013-07-04 WO claimed
US-20130172594-A1 Synthesis of Organohalosilane Monomers Via Enhanced Cleavage of Direct Process Residue MOMENTIVE PERFORMANCE MATERIALS INC. 2013-07-04 US claimed
US-8083945-B2 Fluid storage and purification method and system MATHESON TRI-GAS, INC. (US) 2011-12-27 US claimed
US-20100223208-A1 FLUID STORAGE AND PURIFICATION METHOD AND SYSTEM MATHESON TRI-GAS, INC. (US) 2010-09-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11258100-B2 Electrolyte composition and metal-ion battery employing the same SLC26A3, F8, CLIC1 ACHE 615/4885CA1 62/4885CA2 18/4885
US-20200168954-A1 ELECTROLYTE COMPOSITION AND METAL-ION BATTERY EMPLOYING THE SAME SLC26A3, F8, CLIC1 ACHE 615/4885CA1 62/4885CA2 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.